Biologics, an integrated oncology services company, will continue to help members of the SilverScript Prescription Drug Plan in accessing and affording their oncology therapies. Our clinical expertise in cancer treatments combined with our broad access to both limited and exclusive distribution therapies will insure both access to medications and enhanced continuity of care.
While helping secure copay and other financial assistance needs, Biologics’ Patient Access Services team performs thorough benefits investigation reviews, manages prior authorizations and reports this information back to the prescriber’s office within four hours of receiving the prescription.
“It’s a privilege to help alleviate the financial stress patients often face after receiving a cancer diagnosis, and support them throughout their therapies,” said Dan Duffy, Chief Business Development Officer at Biologics, Inc. “Our high-touch, patient-centered approach to oncology care allows us to support the clinical, financial and emotional needs of our patients.”
About Biologics: Biologics, Inc. is an oncology services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes – clinical, financial and emotional. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to oncology care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing oncology environment and supports patients across all treatment modalities, while providing clinical outcomes and informatics reporting that allow for informed decision making. Since it was founded in 1994, Biologics has been dedicated to improving the lives of those fighting cancer. Privately held, Biologics maintains headquarters and operations in Cary, North Carolina. Visit biologicsinc.com or follow us on Twitter (@BiologicsInc).
